Group 1 - GIC Private Limited increased its stake in Basilea Pharmaceutica AG-B (02616) by 904,500 shares at a price of HKD 5.8476 per share, totaling approximately HKD 5.2892 million [1] - After the increase, GIC's total shareholding rose to about 119 million shares, representing an ownership percentage of 8.06% [1] - GIC's consistent buying activity since first disclosing a 5.49% stake on August 18 indicates strong confidence in Basilea's core value and long-term growth potential [1] Group 2 - GIC has made multiple purchases, with increases reported on October 13 and November 10, raising its stake to 7.11% before the latest increase [1] - Over the four-month period from August 18 to December 23, GIC has accumulated more than 38 million additional shares, reflecting a steady growth in ownership [1]
基石药业-B再获GIC增持！持股比例升至8.06%